The global electroconvulsive therapy market is projected to grow at the highest pace owing to rising demand for ECT treatments for mental health disorders like severe depression, bipolar disorder, and schizophrenia.
Electroconvulsive therapy (ECT) is a medical treatment wherein small electric currents are passed through the brain intentionally triggering a brief seizure. It is primarily used as a treatment for major depression, schizophrenia, and bipolar disorder. ECT is considered to be effective in reducing symptoms and improving functioning in severe and treatment-resistant cases of these mental illnesses. The procedure is often used when other treatments have failed or cannot be used due to medical concerns. ECT works by purposely triggering a brief seizure in the brain through electric stimulation while the patient is under anesthesia.
The Global Electroconvulsive Therapy Market is estimated to be valued at Us$ 16.1 Mn in 2024 and is expected to exhibit a CAGR Of 2.7% over the forecast period 2024 To 2030.
Key players operating in the Global Electroconvulsive Therapy Market Demand are Mecta, Ectron, Somatics, LLC., St.Jude Medical (Abbott).
The increasing prevalence of mental health disorders worldwide combined with inadequate response to pharmacological treatments augments demand for electroconvulsive therapy. According to WHO, depression affects over 264 million people globally and suicide is one of the leading causes of death among young people.
Technological advancements in ECT delivery focus on enhancing safety, efficacy, and tolerability through modifications in electrical waveform characteristics, pulse width, frequency, and electrode placement. The introduction of brief pulse and ultrabrief pulse ECT aims to minimize adverse cognitive effects associated with standard ECT.
- Growing inclination towards brief pulse ECT and ultrabrief pulse ECT: - Brief pulse ECT and ultrabrief pulse ECT help minimize adverse cognitive effects while maintaining therapeutic efficacy. Their adoption is increasing globally.
- Rise in ambulatory and home-based ECT treatment: - Developments facilitating increased access through ambulatory and home-based ECT treatments help overcome barriers like lack of specialized mental healthcare facilities.
- Untapped growth potential in developing regions: - Significant treatment gap exists for mental illnesses in low and middle-income countries representing major opportunities.
- Scope for technological advancements in ECT devices: - Further innovations focusing on factors like reduced seizure threshold, precise stimulation control present opportunities.
Impact of COVID-19 on Global Electroconvulsive Therapy Market Growth
The COVID-19 pandemic has impacted the growth of the global electroconvulsive therapy market significantly. During the pandemic, the demand for electroconvulsive therapy saw a decline as non-essential medical procedures and therapies were postponed or canceled to avoid the risk of virus transmission in healthcare facilities. This led to reduced revenues and sales for key manufacturers in 2020. However, therapies for severe mental health conditions like treatment-resistant depression, bipolar disorder and schizophrenia continued, though with stringent safety protocols.
As the pandemic situation improves globally with widespread vaccination programs, the electroconvulsive therapy market is witnessing a revival post-2021. While remote consultation has increased, in-person therapy sessions are being resumed gradually as hospitals aim to clear backlogs. This is propelling market growth. Additionally, the pandemic has worsened mental health issues among populations worldwide due to stress, loneliness, financial troubles and other factors. This is raising demand for electroconvulsive therapy in treatment. Market players are focusing on ensuring safety, affordability and access to therapy. New product launches catering to safety needs and expansion into emerging markets will be crucial for sustained recovery and future market development.
Geographical Regions with Highest Electroconvulsive Therapy Market Value
North America represents the largest regional market for electroconvulsive therapy globally in terms of value, accounting for around 40% revenue share. This is attributed to factors like well-established healthcare infrastructure, high adoption of new technologies, and favorable reimbursement policies for mental healthcare in countries like the US and Canada. Market growth is steady in North America backed by presence of leading manufacturers, rising awareness about therapy effectiveness and frequent new product launches.
Asia Pacific is the fastest growing regional market for electroconvulsive therapy projected to expand at over 3% CAGR during the forecast period. This growth can be attributed to rising mental healthcare needs of a large patient pool, growing medical tourism, increasing focus of manufacturers on emerging Asian countries and improving access to therapy in nations like China, India and Japan.
Fastest Growing Regional Market for Electroconvulsive Therapy
The Asia Pacific region holds immense growth potential for electroconvulsive therapy market and is emerging as the fastest growing regional market globally. Factors driving strong market growth prospects in Asia Pacific include rapidly growing geriatric population susceptible to mental health conditions, increasing healthcare expenditures, evolving public policies supportive of mental health, rising medical tourism and penetrations of global industry players looking to tap emerging opportunities.
Countries like China, India and South Korea are undergoing major transformations and modernization of their healthcare systems. Mental healthcare is gaining higher priority on national agendas. This is generating significant demand for effective therapies like electroconvulsive therapy. Additionally, presence of medical devices manufacturing hub in certain Asia Pacific countries benefits local product availability, affordability and market expansion. The widespread unmet medical needs, growing economy and healthcare investments in Asia Pacific make it the fastest growing regional market for electroconvulsive therapy.
Get more insights on this topic :